Marcaine/ Epinephrine 0.5% Inj

Manufacturer HOSPIRA Active Ingredient Bupivacaine and Epinephrine(byoo PIV a kane & ep i NEF rin) Pronunciation byoo PIV a kane & ep i NEF rin
WARNING: Seizures, sudden loss of heart function, and death have been reported when this drug was used as an epidural during childbirth. Most of the time, this happened with a certain strength of this drug that is not meant for use during labor. If you have questions, talk with the doctor. @ COMMON USES: It is used to numb an area before a procedure.
đŸˇī¸
Drug Class
Local Anesthetic
đŸ§Ŧ
Pharmacologic Class
Amide Local Anesthetic; Alpha/Beta-Adrenergic Agonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Jan 1970
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

This medication is a combination of two drugs. Bupivacaine is a 'numbing medicine' (local anesthetic) that temporarily blocks nerve signals in a specific area of your body, preventing you from feeling pain. Epinephrine is a medicine that narrows blood vessels, which helps the numbing effect of bupivacaine last longer and reduces bleeding in the area where it's injected.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. It is essential to follow the instructions carefully. This medication is administered via injection.

Storing and Disposing of Your Medication

This medication will be administered in a hospital or doctor's office, so you will not need to store it at home.

Missing a Dose

Since this medication is given as needed in a healthcare setting, you will not need to worry about missing a dose. The healthcare provider will administer the medication according to your specific needs.
💡

Lifestyle & Tips

  • Avoid touching or manipulating the numb area until sensation returns to prevent injury.
  • Follow post-procedure instructions carefully, especially regarding activity restrictions.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Highly variable based on procedure, site, and patient factors. Always use the lowest effective dose. Max single dose of bupivacaine with epinephrine is typically 225 mg (or 3 mg/kg, whichever is less) for infiltration/nerve block, not to exceed 400 mg in 24 hours. For epidural, max single dose is typically 175 mg.

Condition-Specific Dosing:

infiltration: Up to 225 mg (45 mL of 0.5%)
peripheralNerveBlock: Up to 225 mg (45 mL of 0.5%)
epiduralBlock: 75-175 mg (15-35 mL of 0.5%)
caudalBlock: 75-150 mg (15-30 mL of 0.5%)
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established (use with extreme caution, lower concentrations preferred)
Infant: Not established (use with extreme caution, lower concentrations preferred)
Child: 0.25-0.5% solution, max dose 2.5 mg/kg (not to exceed 2.5 mg/kg per dose or 400 mg/24 hours, whichever is less). Dosing must be individualized based on age, weight, and procedure.
Adolescent: Similar to adult dosing, but based on weight and physiological maturity, max 2.5 mg/kg or 225 mg, whichever is less.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment recommended, but monitor for systemic toxicity.
Moderate: No specific adjustment recommended, but monitor for systemic toxicity.
Severe: No specific adjustment recommended, but monitor for systemic toxicity due to potential accumulation of metabolites.
Dialysis: Considerations: Bupivacaine is not significantly dialyzable. Monitor closely for signs of systemic toxicity.

Hepatic Impairment:

Mild: Use with caution; consider lower doses.
Moderate: Use with caution; consider lower doses and extended dosing intervals due to impaired metabolism.
Severe: Contraindicated or use with extreme caution; significantly reduced metabolism can lead to accumulation and toxicity.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Bupivacaine, an amide-type local anesthetic, reversibly blocks the initiation and conduction of nerve impulses by decreasing the permeability of the nerve cell membrane to sodium ions. This stabilizes the membrane and inhibits depolarization, leading to a failure to propagate the action potential. Epinephrine, an alpha- and beta-adrenergic agonist, causes vasoconstriction at the site of injection, which prolongs the duration of bupivacaine's action, reduces its systemic absorption, and provides local hemostasis.
📊

Pharmacokinetics

Absorption:

Bioavailability: Highly variable; depends on site of injection, dose, vascularity of tissue, and presence of epinephrine. Epinephrine reduces the rate of absorption of bupivacaine.
Tmax: Varies widely (e.g., 10-60 minutes for epidural, longer for peripheral blocks).
FoodEffect: Not applicable (parenteral administration).

Distribution:

Vd: Approximately 0.7 L/kg (bupivacaine)
ProteinBinding: Approximately 95% (bupivacaine, primarily to alpha-1-acid glycoprotein)
CnssPenetration: Yes (crosses blood-brain barrier, responsible for CNS effects/toxicity)

Elimination:

HalfLife: Approximately 2.7 hours (bupivacaine, in adults); Epinephrine has a very short half-life (minutes).
Clearance: Approximately 0.58 L/min (bupivacaine)
ExcretionRoute: Renal (bupivacaine and metabolites); Epinephrine metabolites are renally excreted.
Unchanged: Approximately 5% (bupivacaine)
âąī¸

Pharmacodynamics

OnsetOfAction: 2-10 minutes (infiltration/nerve block); 5-10 minutes (epidural/caudal)
PeakEffect: 30-45 minutes
DurationOfAction: 3-7 hours (infiltration/nerve block); 4-8 hours (epidural/caudal), prolonged by epinephrine.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

There have been reports of cardiac arrest with difficult resuscitation or death during use of bupivacaine for epidural anesthesia in obstetrical patients. In most cases, this has followed accidental intravascular injection of bupivacaine and some cases have been reported after the administration of bupivacaine for epidural anesthesia in non-obstetrical patients. The 0.75% concentration of bupivacaine is not recommended for obstetrical anesthesia. Resuscitation efforts should be immediately available when bupivacaine is administered.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of acidosis (too much acid in the blood):
+ Confusion
+ Fast breathing
+ Fast heartbeat
+ Irregular heartbeat
+ Severe stomach pain, upset stomach, or vomiting
+ Excessive sleepiness
+ Shortness of breath
+ Feeling extremely tired or weak
Signs of methemoglobinemia (a rare but potentially life-threatening condition):
+ Blue or gray discoloration of the lips, nails, or skin
+ Irregular heartbeat
+ Seizures
+ Severe dizziness or fainting
+ Severe headache
+ Excessive sleepiness
+ Feeling extremely tired or weak
+ Shortness of breath
Other severe side effects:
+ Feeling extremely hot or cold
+ Dizziness or fainting
+ Lightheadedness, sleepiness, confusion, or blurred vision
+ Balance problems
+ Restlessness
+ Anxiety
+ Changes in speech
+ Numbness or tingling in the mouth
+ Metallic taste
+ Ringing in the ears
+ Shakiness
+ Twitching
+ Seizures
+ Breathing difficulties, slow breathing, or shallow breathing
+ Abnormal burning, numbness, or tingling sensations
+ Feeling nervous and excitable
+ Headache
+ Severe stomach upset or vomiting
+ Abnormal heartbeat, chest pain, or pressure
+ Fever or chills
+ Sneezing
+ Excessive sweating
+ Skin reactions at the injection site, such as burning, color changes, pain, skin breakdown, or swelling
* Spinal-related side effects:
+ Urination difficulties
+ Loss of bladder or bowel control
+ Erectile dysfunction
+ Long-lasting burning, numbness, tingling, or paralysis in the lower half of the body
+ Back pain
+ Stiff neck
+ Sensitivity to bright lights

Other Possible Side Effects

Like all medications, this drug can cause side effects, although not everyone will experience them. If you have any side effects that bother you or do not go away, contact your doctor for advice. This is not an exhaustive list of possible side effects. If you have questions or concerns, discuss them with your doctor.

Reporting Side Effects

You can report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Feeling lightheaded, dizzy, or faint
  • Ringing in your ears (tinnitus)
  • Numbness or tingling around your mouth
  • A metallic taste in your mouth
  • Blurred vision or difficulty seeing clearly
  • Tremors or muscle twitching
  • Feeling anxious or restless
  • Slurred speech
  • Feeling unusually sleepy or confused
  • Seizures
  • Difficulty breathing or shortness of breath
  • Chest pain or discomfort
  • Feeling your heart race or beat irregularly (palpitations)
  • Unusual weakness or numbness spreading beyond the intended area
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have to this medication, its components, or other substances, including foods and drugs. Describe the allergic reaction you experienced, such as symptoms and signs.
Certain health conditions, including:
+ Bleeding disorders
+ Abnormal heart rhythms
+ Blood infections or infections at the site where the medication will be administered
+ Low blood pressure (hypotension)
If you are taking specific medications, such as:
+ Antidepressants like isocarboxazid, phenelzine, or tranylcypromine
+ Medications for Parkinson's disease, including selegiline or rasagiline
+ Tricyclic antidepressants like amitriptyline, amoxapine, clomipramine, desipramine, doxepin, imipramine, nortriptyline, protriptyline, or trimipramine
+ Beta blockers like nadolol, propranolol, sotalol, or timolol
All your current medications, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This is not an exhaustive list, and it is crucial to disclose all your medications and health conditions to your doctor.

To ensure your safety, consult your doctor and pharmacist about all your medications and health problems before taking this medication. Do not initiate, stop, or modify the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

General Precautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Until the effects of this drug have worn off and you feel fully alert, avoid driving and other activities that require your full attention.

If you have a sulfite allergy, consult your doctor, as some products contain sulfites. A rare but serious blood condition called methemoglobinemia has been associated with this type of medication. Your risk may be increased if you have glucose-6-phosphate dehydrogenase (G6PD) deficiency, heart or lung problems, or are taking certain other medications. Infants under 6 months of age are also at higher risk. If you have a history of methemoglobinemia, inform your doctor.

Special Considerations

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Not all products are suitable for children, so consult your doctor before use.

If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential benefits and risks with your doctor to ensure the best outcome for you and your baby.

Specific Warnings

Mouth: Avoid eating while your mouth is numb, as you may accidentally bite your tongue.
Spinal: This medication may cause temporary loss of sensation and motor function in the lower half of your body. Do not attempt to get out of bed or perform other activities until normal feeling and movement have returned.
🆘

Overdose Information

Overdose Symptoms:

  • Severe dizziness or lightheadedness
  • Profound drowsiness or loss of consciousness
  • Generalized seizures
  • Severe low blood pressure (hypotension)
  • Slow heart rate (bradycardia) or very fast heart rate (tachycardia)
  • Irregular heartbeats (arrhythmias), including life-threatening ventricular fibrillation or cardiac arrest
  • Respiratory depression or apnea (stopping breathing)

What to Do:

Immediate medical attention is required. Call 911 or your local emergency number. Management involves supportive care, maintaining airway and breathing, managing seizures (e.g., with benzodiazepines), and treating cardiovascular collapse (e.g., with vasopressors, lipid emulsion therapy for bupivacaine toxicity). Call 1-800-222-1222 (Poison Control) for additional guidance.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Intravenous regional anesthesia (Bier block)
  • Obstetric paracervical block (due to fetal bradycardia/death)
  • Use in areas with end-arteries (e.g., fingers, toes, nose, penis, earlobe) due to risk of ischemia/necrosis.
🔴

Major Interactions

  • Monoamine Oxidase Inhibitors (MAOIs): Potentiate pressor effects of epinephrine, leading to hypertensive crisis.
  • Tricyclic Antidepressants (TCAs): Potentiate pressor effects of epinephrine, leading to severe prolonged hypertension.
  • Ergot-type Oxytocic Drugs (e.g., methylergonovine): May cause severe persistent hypertension or cerebrovascular accidents when used with vasoconstrictors like epinephrine.
  • General Anesthetics (e.g., halothane, enflurane): May sensitize the myocardium to the effects of epinephrine, increasing risk of arrhythmias.
  • Other Local Anesthetics: Additive systemic toxicity.
  • Antiarrhythmics (e.g., Class I antiarrhythmics like lidocaine, mexiletine): Additive cardiac effects, increased risk of toxicity.
🟡

Moderate Interactions

  • Non-selective Beta-blockers (e.g., propranolol): May enhance the pressor response to epinephrine, leading to hypertension and bradycardia.
  • Phenothiazines and Butyrophenones: May reverse the pressor effect of epinephrine, leading to hypotension.
  • Alpha-adrenergic Blockers: May antagonize the vasoconstrictor effects of epinephrine.
  • Digitalis Glycosides: Increased risk of cardiac arrhythmias with epinephrine.
đŸŸĸ

Minor Interactions

  • Not typically categorized for this drug combination, as most interactions are significant.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Patient assessment (medical history, allergies, current medications)

Rationale: To identify contraindications, potential drug interactions, and risk factors for toxicity.

Timing: Prior to administration

Vital signs (heart rate, blood pressure, respiratory rate, oxygen saturation)

Rationale: To establish baseline and detect early signs of systemic toxicity or adverse reactions.

Timing: Prior to administration

Aspiration check

Rationale: To ensure needle is not in a blood vessel, minimizing risk of intravascular injection and systemic toxicity.

Timing: Before and during injection

📊

Routine Monitoring

Vital signs (heart rate, blood pressure, respiratory rate, oxygen saturation)

Frequency: Every 5-15 minutes during and immediately after injection, then as clinically indicated.

Target: Within patient's normal physiological range.

Action Threshold: Significant deviations (e.g., hypotension, bradycardia, tachycardia, hypertension, desaturation) warrant immediate intervention.

Neurological status (level of consciousness, presence of CNS symptoms)

Frequency: Continuously during and for at least 30 minutes after injection.

Target: Alert and oriented, no signs of CNS toxicity.

Action Threshold: Lightheadedness, dizziness, tinnitus, perioral numbness, metallic taste, visual disturbances, tremors, muscle twitching, seizures.

ECG monitoring

Frequency: Continuous during and immediately after injection, especially with large volumes or high-risk patients.

Target: Normal sinus rhythm, no significant arrhythmias.

Action Threshold: Bradycardia, tachycardia, ventricular arrhythmias, QRS widening, ST segment changes.

Pain assessment and sensory/motor block level

Frequency: As needed to assess efficacy and progression of block.

Target: Desired level of anesthesia/analgesia.

Action Threshold: Inadequate block or signs of excessive spread.

đŸ‘ī¸

Symptom Monitoring

  • Lightheadedness
  • Dizziness
  • Tinnitus (ringing in ears)
  • Perioral numbness
  • Metallic taste
  • Visual disturbances (blurred vision, difficulty focusing)
  • Tremors
  • Muscle twitching
  • Slurred speech
  • Anxiety
  • Restlessness
  • Drowsiness
  • Disorientation
  • Seizures
  • Loss of consciousness
  • Hypotension
  • Bradycardia
  • Tachycardia
  • Hypertension
  • Arrhythmias (ventricular fibrillation, asystole)
  • Respiratory depression
  • Apnea
  • Chest pain
  • Palpitations
  • Nausea
  • Vomiting

Special Patient Groups

🤰

Pregnancy

Category C. Use only if the potential benefit justifies the potential risk to the fetus. Bupivacaine crosses the placenta. Epinephrine can reduce uterine blood flow. Obstetric paracervical block is contraindicated due to risk of fetal bradycardia and death.

Trimester-Specific Risks:

First Trimester: Potential for teratogenicity not well-established, but generally avoided unless essential.
Second Trimester: Use with caution; monitor maternal and fetal status closely.
Third Trimester: Use with caution; monitor maternal and fetal status closely. Contraindicated for obstetric paracervical block. Accidental intravascular injection can lead to severe maternal and fetal toxicity.
🤱

Lactation

L3 (Moderately safe). Bupivacaine is excreted into breast milk in small amounts. The amount ingested by the infant is generally considered too low to cause adverse effects. Epinephrine has a very short half-life and is unlikely to be present in breast milk in significant amounts. Monitor infant for drowsiness or feeding difficulties.

Infant Risk: Low risk of adverse effects, but monitor for unusual drowsiness or feeding changes.
đŸ‘ļ

Pediatric Use

Use with extreme caution. Dosing must be carefully calculated based on weight and age, using the lowest effective concentration and volume. Children may be more susceptible to systemic toxicity. Avoid in very young infants if possible. The 0.75% concentration is not recommended for children.

👴

Geriatric Use

Use with caution. Elderly patients may be more susceptible to systemic toxicity due to decreased hepatic function, reduced plasma protein binding, and altered body composition. Consider lower doses and slower injection rates. Monitor closely for CNS and cardiovascular effects.

Clinical Information

💎

Clinical Pearls

  • Always aspirate frequently and in multiple planes before and during injection to minimize the risk of accidental intravascular administration, which can lead to severe systemic toxicity.
  • Use the lowest effective concentration and volume to achieve the desired block, especially in high-risk areas or patients.
  • Epinephrine prolongs the duration of action and reduces systemic absorption of bupivacaine, but it also adds its own cardiovascular effects (tachycardia, hypertension, arrhythmias).
  • Contraindicated for use in areas supplied by end-arteries (e.g., fingers, toes, nose, penis, earlobe) due to the risk of vasoconstriction-induced ischemia and necrosis.
  • Be prepared to manage systemic toxicity (CNS and cardiovascular) with appropriate resuscitation equipment and medications (e.g., lipid emulsion therapy for bupivacaine toxicity).
  • Monitor patients closely for signs of CNS toxicity (e.g., lightheadedness, tinnitus, perioral numbness, seizures) and cardiovascular toxicity (e.g., hypotension, bradycardia, arrhythmias).
🔄

Alternative Therapies

  • Other local anesthetics without epinephrine (e.g., plain bupivacaine, lidocaine, ropivacaine)
  • Regional anesthesia techniques without local anesthetic/epinephrine combination (e.g., nerve blocks with plain local anesthetic)
  • General anesthesia
  • Systemic analgesics (e.g., opioids, NSAIDs)
  • Non-pharmacological pain management techniques
💰

Cost & Coverage

Average Cost: Varies widely (e.g., $5 - $50+ per vial/ampule depending on size, concentration, and supplier) per vial/ampule
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (typically covered as part of a medical procedure)
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed otherwise, do not flush medications down the toilet or drain. If you are unsure about the proper disposal method, consult your pharmacist, as they can provide guidance or inform you about potential drug take-back programs in your area. Some medications may come with an additional patient information leaflet, so it is a good idea to check with your pharmacist. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred, as this will aid in receiving appropriate care.